Structure-based design of oligomeric receptor-binding domain (RBD) recombinant proteins as potent vaccine candidates against SARS-CoV-2
The receptor-binding domain (RBD) of SARS-CoV-2 S protein is proved to be the major target of neutralizing antibodies. However, on the S protein, only a portion of epitopes in RBD can be effectively displayed with dynamic changes in spatial conformations. Using RBD fragment as antigen can better exp...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2023-01-01
|
| Collection: | Human Vaccines & Immunotherapeutics |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.1080/21645515.2023.2174755 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|